Date: Thursday, August 28th
Time: 10:00 – 11:00 a.m. (PST)/1:00-2:00pm EDT
This WuXi AppTec event is complementary and open to life science professionals globally.
Click HERE for registration and additional information.
WHAT WILL BE COVERED
This webinar will discuss utilizing various expression systems for rapid production of milligram to gram scale proteins to support research material generation and early stage program development needs. We will also present and compare regulatory-compliant mammalian cell line development platforms for manufacturing various biopharmaceuticals including mAbs, recombinant and fusion proteins.
- Protein expression evaluation and fast research material generation by transient transfection and stable pool production in microbial and mammalian systems
- FDA and EMA compliant manufacturing cell line development using CHO DG44 and CHO K1 cells
- Detailed case studies to illustrate the pros and cons of the cell line development platforms
- Analytical characterization strategies and tools for biopharmaceuticals during cell line development
SPEAKERS / Q&A PANEL
Weichang Zhou, PhD Vice President, Biologics Development • WuXi AppTec
Jill Cai, MS Executive Director, Cell Line Development • WuXi AppTec